Malignant astrocytic glioma: genetics, biology, and paths to treatment, Genes & Development, vol.21, issue.21, pp.2683-2710, 2007. ,
DOI : 10.1101/gad.1596707
An Integrated Genomic Analysis of Human Glioblastoma Multiforme, Science, vol.321, issue.5897, pp.1807-1812, 2008. ,
DOI : 10.1126/science.1164382
Tenets of PTEN Tumor Suppression, Cell, vol.133, issue.3, pp.403-414, 2008. ,
DOI : 10.1016/j.cell.2008.04.013
Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity, Cell, vol.128, issue.1, pp.157-170, 2007. ,
DOI : 10.1016/j.cell.2006.11.042
Poly(ADP-ribose): novel functions for an old molecule, Nature Reviews Molecular Cell Biology, vol.116, issue.7, pp.517-528, 2006. ,
DOI : 10.1038/nrm1963
URL : https://hal.archives-ouvertes.fr/hal-00129983
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs, Nature Reviews Molecular Cell Biology, vol.10, issue.7, pp.411-424, 2012. ,
DOI : 10.1038/nrm3376
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase, Nature, vol.20, issue.7035, pp.913-917, 2005. ,
DOI : 10.1016/S0022-2836(03)00313-9
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy, Nature, vol.11, issue.7035, pp.917-921, 2005. ,
DOI : 10.1177/1087057103008003013
Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition, Cancer Research, vol.66, issue.16, pp.8109-8115, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-0140
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers, N Engl J Med, issue.2, pp.361123-134, 2009. ,
Phosphorylation of ribosomal protein S6 confers PARP inhibitor resistance in BRCA1-deficient cancers, Oncotarget, vol.5, issue.10, pp.3375-3385, 2014. ,
DOI : 10.18632/oncotarget.1952
Histone deacetylase inhibitor treatment induces ???BRCAness??? and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells, Oncotarget, vol.5, issue.14, pp.5637-5650, 2014. ,
DOI : 10.18632/oncotarget.2154
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170637
Rationale for Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Combination Therapy with Camptothecins or Temozolomide Based on PARP Trapping versus Catalytic Inhibition, Journal of Pharmacology and Experimental Therapeutics, vol.349, issue.3, pp.408-416, 2014. ,
DOI : 10.1124/jpet.113.210146
Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells, Cell Death and Differentiation, vol.47, issue.2, pp.258-269, 2014. ,
DOI : 10.1111/j.1744-7348.1939.tb06990.x
PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation, Oncotarget, vol.2, issue.12, pp.984-996, 2011. ,
DOI : 10.18632/oncotarget.362
PTEN Loss Compromises Homologous Recombination Repair in Astrocytes: Implications for Glioblastoma Therapy with Temozolomide or Poly(ADP-Ribose) Polymerase Inhibitors, Cancer Research, vol.70, issue.13, pp.5457-5464 ,
DOI : 10.1158/0008-5472.CAN-09-4295
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors, EMBO Mol Med, vol.1, pp.6-7315, 2009. ,
PTEN Loss Compromises Homologous Recombination Repair in Astrocytes: Implications for Glioblastoma Therapy with Temozolomide or Poly(ADP-Ribose) Polymerase Inhibitors, Cancer Research, vol.70, issue.13, pp.5457-5464, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-4295
Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway, EMBO reports, vol.19, issue.5, pp.470-476, 2011. ,
DOI : 10.1038/sj.onc.1208311
Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells, Journal of Visualized Experiments, issue.78, p.50568, 2013. ,
DOI : 10.3791/50568
A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells, BMC Cancer, vol.26, issue.6, p.412, 2011. ,
DOI : 10.1038/sj.onc.1210879
Type I IFNs signaling and apoptosis resistance in glioblastoma cells Apoptosis : an international journal on programmed cell death, pp.1229-1244, 2011. ,
Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan, Nature Cell Biology, vol.19, issue.1, pp.96-102, 2013. ,
DOI : 10.1182/blood-2010-02-268391
Assaying Double???Strand Break Repair Pathway Choice in Mammalian Cells Using a Targeted Endonuclease or the RAG Recombinase, Methods Enzymol, vol.409, pp.524-540, 2006. ,
DOI : 10.1016/S0076-6879(05)09031-2
PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer research, pp.6318-6322, 2002. ,
U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line, PLoS Genetics, vol.19, issue.1, p.1000832, 2010. ,
DOI : 10.1371/journal.pgen.1000832.s009
Aneuploidy in health, disease, and aging, The Journal of Cell Biology, vol.61, issue.1, pp.11-21, 2013. ,
DOI : 10.1371/journal.pgen.1002719
The human mitotic checkpoint protein BubR1 regulates chromosome???spindle attachments, Nature Cell Biology, vol.62, issue.1, pp.93-98, 2005. ,
DOI : 10.1083/jcb.137.7.1567
The spindle-assembly checkpoint in space and time, Nature Reviews Molecular Cell Biology, vol.6, issue.5, pp.379-393, 2007. ,
DOI : 10.1038/nrm2163
Cancer-Specific Requirement for BUB1B/BUBR1 in Human Brain Tumor Isolates and Genetically Transformed Cells, Cancer Discovery, vol.3, issue.2, pp.198-211, 2013. ,
DOI : 10.1158/2159-8290.CD-12-0353
Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130, Proceedings of the National Academy of Sciences, vol.107, issue.5, pp.2201-2206, 2010. ,
DOI : 10.1073/pnas.0904783107
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide, BMC Cancer, vol.72, issue.1, p.151, 2014. ,
DOI : 10.1007/s00280-013-2175-0
URL : https://hal.archives-ouvertes.fr/pasteur-01164062
N-methylpurine DNA glycosylase and DNA polymerase ?? modulate BER inhibitor potentiation of glioma cells to temozolomide, Neuro-Oncology, vol.13, issue.5, pp.471-486, 2011. ,
DOI : 10.1093/neuonc/nor011
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012, Cell Death and Differentiation, vol.94, issue.1, pp.107-120, 2012. ,
DOI : 10.1083/jcb.200712051
Mitotic catastrophe: a mechanism for avoiding genomic instability, Nature Reviews Molecular Cell Biology, vol.29, issue.6, pp.385-392, 2011. ,
DOI : 10.1038/nrm3115
Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo?, Clinical Cancer Research, vol.15, issue.19, pp.6106-6112, 2009. ,
DOI : 10.1158/1078-0432.CCR-09-0398
The role of p38 signaling and poly(ADP-ribosyl)ation-induced metabolic collapse in the osteogenic differentiation-coupled cell death pathway, Free Radical Biology and Medicine, vol.76, pp.69-79, 2014. ,
DOI : 10.1016/j.freeradbiomed.2014.07.027
Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors, Oncotarget, vol.5, issue.10, pp.3023-3028, 2014. ,
DOI : 10.18632/oncotarget.1814
CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors, BMC Cancer, vol.4, issue.5, p.66, 2010. ,
DOI : 10.1016/j.stem.2009.03.003
URL : https://hal.archives-ouvertes.fr/inserm-00663773
A rapid, quantitative and inexpensive method for detecting apoptosis by flow cytometry in transiently transfected cells, Nucleic Acids Research, vol.25, issue.23, pp.4855-4857, 1997. ,
DOI : 10.1093/nar/25.23.4855